Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Hajjaji · SciRah

Researcher profile · Semantic Scholar

N. Hajjaji

Share profile

N. Hajjaji — researcher profile on SciRah

h-index: 15
Works: 50
Citations: 1,102

Most-cited papers

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial
P. Bougnoux, N. Hajjaji, M. N. Ferrasson, B. Giraudeau +2 more
2009British Journal of Cancer279 citations Open access
Semantic Scholar
Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth.
P. Bougnoux, N. Hajjaji, K. Mahéo, C. Couet +1 more
2010Progress in lipid research153 citations
Semantic Scholar
Genomics to select treatment for patients with metastatic breast cancer
F. André, T. Filleron, M. Kamal, F. Mosele +35 more
2022Nature150 citations
Semantic Scholar
Selective sensitization of tumors to chemotherapy by marine-derived lipids: a review.
N. Hajjaji, P. Bougnoux
2013Cancer Treatment Reviews93 citations
Semantic Scholar
Bone infection in cat-scratch disease: a review of the literature.
N. Hajjaji, Laurent Hocqueloux, R. Kerdraon, L. Bret
2007Journal of Infection89 citations
Semantic Scholar
The lipidome as a composite biomarker of the modifiable part of the risk of breast cancer.
P. Bougnoux, N. Hajjaji, C. Couet
2008Prostaglandins, Leukotrienes and Essential Fatty Acids36 citations
Semantic Scholar
A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses
A. Raffo-Romero, Lydia Ziane-Chaouche, Sophie Salomé-Desnoulez, N. Hajjaji +3 more
2024Cell Reports Methods33 citations Open access
Semantic Scholar
Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy
Mélanie Rose, T. Cardon, S. Aboulouard, N. Hajjaji +4 more
2021Frontiers in Immunology33 citations Open access
Semantic Scholar
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
D. Pasquier, L. Bidaut, D. Oprea-Lager, N. Desouza +34 more
2023The Lancet Oncology28 citations Open access
Semantic Scholar
Inhibition of furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities
Lydia Ziane-Chaouche, A. Raffo-Romero, N. Hajjaji, Firas H. Kobeissy +8 more
2024Cell Death and Disease27 citations Open access
Semantic Scholar
DHA Effect on Chemotherapy-Induced Body Weight Loss: An Exploratory Study in a Rodent Model of Mammary Tumors
N. Hajjaji, C. Couet, P. Besson, P. Bougnoux
2012Nutrition and Cancer25 citations
Semantic Scholar
Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis
M. Wisztorski, S. Aboulouard, Lucas Roussel, M. Duhamel +11 more
2023Cell Death and Disease24 citations Open access
Semantic Scholar
Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats
N. Hajjaji, P. Besson, P. Bougnoux
2012Cancer Chemotherapy and Pharmacology22 citations
Semantic Scholar
Determinants of DHA Incorporation into Tumor Tissue During Dietary DHA Supplementation
N. Hajjaji, V. Schubnel, P. Bougnoux
2011Lipids19 citations Open access
Semantic Scholar
Docosahexaenoic acid (DHA) intake during first line chemotherapy improves survival in metastatic breast cancer.
P. Bougnoux, N. Hajjaji, Marie-Ange Baucher, M. Jourdan +3 more
200619 citations
Semantic Scholar
Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France
T. Petit, N. Hajjaji, Eric-Charles Antoine, M. Benderra +21 more
2024Cancer Medicine14 citations Open access
Semantic Scholar
Automatic Classification of Tumor Response From Radiology Reports With Rule-Based Natural Language Processing Integrated Into the Clinical Oncology Workflow
Gery Laurent, Franck Craynest, Maxime Thobois, N. Hajjaji
2023JCO Clinical Cancer Informatics13 citations Open access
Semantic Scholar
Path to Clonal Theranostics in Luminal Breast Cancers
N. Hajjaji, S. Aboulouard, T. Cardon, D. Bertin +3 more
2021Frontiers in Oncology11 citations Open access
Semantic Scholar
Establishment and characterization of canine mammary tumoroids for translational research
A. Raffo-Romero, S. Aboulouard, E. Bouchaert, A. Rybicka +5 more
2023BMC Biology9 citations Open access
Semantic Scholar
16 Months Follow Up of Patients’ Behavior and Mild COVID-19 Patterns in a Large Cohort of Cancer Patients During the Pandemic
N. Hajjaji, Kathleen Lepoutre, Sarra Lakhdar, S. Becourt +5 more
2022Frontiers in Oncology9 citations Open access
Semantic Scholar
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
Alexandre de Moura, P. Vuagnat, B. Renouf, J. Pierga +15 more
2023Scientific Reports5 citations Open access
Semantic Scholar
Protocol for generating a co-culture of macrophages with breast cancer tumoroids
A. Raffo-Romero, Lydia Ziane-Chaouche, N. Hajjaji, M. Salzet +1 more
2024STAR Protocols4 citations Open access
Semantic Scholar
Should a Multigene Signature be Used in all Luminal Early Breast Cancers
N. Hajjaji, Y. Robin, J. Bonneterre
2019Frontiers in Oncology3 citations Open access
Semantic Scholar
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
S. Potter, Kerry Avery, R. Ahmed, J. de Boniface +337 more
2025npj Breast Cancer2 citations Open access
Semantic Scholar
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer, in real‐life settings
D. Héquet, N. Hajjaji, E. Charafe-Jauffret, A. Boucrauta +11 more
2023Cancer Medicine2 citations Open access
Semantic Scholar
A novel proteomic mass spectrometry-based approach to reveal functionally heterogeneous tumor clones in breast cancer metastases and identify clone-specific drug targets.
N. Hajjaji, Mira Abbouchi, L. Nguyen, S. Charles +5 more
20202 citations
Semantic Scholar
Clone-By-Clone Therapy Guidance in Luminal Breast Cancer Via Spatial Proteomics and Patient-Derived Tumoroid
Laurine Lagache, A. Raffo-Romero, M. Duhamel, Y. Zirem +4 more
2026Molecular & Cellular Proteomics1 citations Open access
Semantic Scholar
Establishment and characterization of a tumoroid biobank derived from dog patients’ mammary tumors for translational research
A. Raffo-Romero, S. Aboulouard, E. Bouchaert, A. Rybicka +5 more
2022bioRxiv1 citations Open access
Semantic Scholar
Early breast cancer classified as intermediate risk by the Prosigna assay: Characteristics and treatment strategy.
N. Hajjaji, Y. Robin, D. Bertin, Jacques Bonneterre
2018Annals of Oncology1 citations Open access
Semantic Scholar
Myosite Mycobacterium chelonae
N. Hajjaji, B. Cattier, P. Lanotte, Annick Legras +1 more
20041 citations
Semantic Scholar
Tumoroïdes comme outil d’étude du rôle du microenvironnement immunitaire ou de nouveaux traitements pharmacologiques dans le cancer du sein
M. Duhamel, A. Raffo-Romero, N. Hajjaji, M. Salzet
2026Annales d'Endocrinologie0 citations Open access
Semantic Scholar
ECLECTIC: 18 F-fluoroestradiol PET and circulating biomarkers to guide the choice of the second line therapy for ER+, HER2- metastatic breast cancer: A phase 3 trial.
F. Bidard, A. Bellesoeur, N. Hajjaji, Elise Rowinski +8 more
2024Journal of Clinical Oncology0 citations
Semantic Scholar
De-escalating therapy dilemma in small HER2 positive node negative breast cancer.
N. Hajjaji
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract P2-13-26: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): First real-life data from the cohort temporary authorization for use (cATU) program in France
T. Petit, N. Hajjaji, É. Antoine, M. Benderra +21 more
2022Cancer Research0 citations
Semantic Scholar
Identifying Diagnostic Markers for Early the Preneoplastic Transformation of Fimbria Lesions at the Origin of Ovarian Cancer in BRCA Mutated Patients
M. Wisztorski, S. Aboulouard, Lucas Roussel, M. Duhamel +11 more
2022Social Science Research Network0 citations Open access
Semantic Scholar
326P National multicentre retrospective study on metastatic breast cancer patients to characterize long responder under eribulin: LORELINE study
Mouret Reynier, M. Paillard, L. Uwer, I. Molnar +10 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
175P Prosigna test for early breast cancer patients in real-life
D. Héquet, R. Rouzier, F. Lerebours, E. Menet +11 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
178P Age-related mutational landscape of luminal breast cancers
N. Hajjaji
2021Annals of Oncology0 citations Open access
Semantic Scholar
Path to drugging functional clones of luminal breast cancers using in-depth proteomics with spatially resolved mass spectrometry guided by MALDI imaging
N. Hajjaji, S. Aboulouard, T. Cardon, D. Bertin +3 more
2021medRxiv0 citations Open access
Semantic Scholar
Abstract PS18-36: Proteomic profiling of specific tumor clones using spatially resolved mass spectrometry technologies for precision oncology
N. Hajjaji, S. Aboulouard, D. Bertin, Y. Robin +2 more
20210 citations
Semantic Scholar
1708P Online survey on SARS-CoV-2 infections in cancer patients during a nationwide lockdown in France
N. Hajjaji, S. Lakhdar, E. Kaczmarek, C. Bellier +5 more
2020Annals of Oncology0 citations Open access
Semantic Scholar
Abstract P4-07-08: Functional proteomic characterization of early luminal breast cancers with discordant genomic and clinical risk estimates
N. Hajjaji, S. Aboulouard, Y. Robin, D. Bertin +3 more
2020Poster Session Abstracts0 citations
Semantic Scholar
Proteomic profile of high-risk luminal A early breast cancers.
N. Hajjaji, S. Aboulouard, Y. Robin, D. Bertin +3 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract P3-08-15: Proteomic profile of PAM50 intermediate risk early breast cancers
N. Hajjaji, S. Aboulouard, YM Robin, D. Bertin +3 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Abstract P3-08-19: Proteomic tracking of breast cancer metastasis progression
N. Hajjaji, S. Aboulouard, YM Robin, D. Bertin +3 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Abstract 1051: Activation of PI3K pathway in breast cancer associates with tumor phospholipid fatty acid composition
N. Hajjaji, F. Arbion, A. Fautrel, C. Villalva +2 more
20160 citations
Semantic Scholar
Predictive value of hypercholesterolemia on progression free survival in patients treated with everolimus for renal cell carcinoma.
Armelle Vinceneux, A. Flechon, H. Boyle, H. Végas +2 more
20150 citations
Semantic Scholar
Abstract 3842: Relationship between weight change and response to trastuzumab-based neoadjuvant chemotherapy among women with operable HER2 overexpressing breast cancer
N. Hajjaji, Dorothée Chocteau, S. Gerard, M. Orgerie
20140 citations
Semantic Scholar
Abstract P1-09-21: Impact of the benfluorex scandal on French cancer patients’ attitude toward clinical trials
N. Hajjaji
20130 citations
Semantic Scholar
[Is staging bone scan useful in patients with small invasive breast carcinoma?].
E. Simon, H. Marret, I. Barillot, A. Bougnoux +2 more
2009Gynécologie Obstétrique & Fertilité0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Salzet×15
Invite
M. Salzet — researcher profile on SciRah
S. Aboulouard×13
Invite
S. Aboulouard — researcher profile on SciRah
I. Fournier×13
Invite
I. Fournier — researcher profile on SciRah
D. Bertin×11
Invite
D. Bertin — researcher profile on SciRah

×10

Invite

M. Duhamel — researcher profile on SciRah

Invite

Y. Robin — researcher profile on SciRah

Invite

P. Bougnoux — researcher profile on SciRah

A. Raffo-Romero×7

Invite

A. Raffo-Romero — researcher profile on SciRah

Invite

T. Cardon — researcher profile on SciRah

J. Bonneterre×5

Invite

J. Bonneterre — researcher profile on SciRah

Invite

C. Couet — researcher profile on SciRah

Invite

N. Dohollou — researcher profile on SciRah